Literature DB >> 8972708

Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines.

R Zeisig1, K Shimada, S Hirota, D Arndt.   

Abstract

A serious problem using liposomes for therapeutic purposes is the fast removal from blood circulation by components of the reticuloendothelial system (RES) most likely after opsonization of the vesicles. This study was performed to quantify the reduction in macrophage uptake in vitro of sterically stabilized liposomes (PEG-liposomes) prepared from hexadecylphosphocholine, cholesterol and poly(ethylene glycol2000) distearoylphosphoethanolamine (PEG2000DSPE) for the first time. The uptake was determined using HPC-liposomes of different defined size (125, 250 and 1000 nm) without and with sterical stabilization by incorporating 5 mol% of PEG2000DSPE. HPTS was used as fluorescence marker allowing the discrimination between general uptake and the part of liposomes internalized into the low pH-compartment (Daleke, L.D., Hong, K. and Papahadjopoulos. D. (1990) Biochim. Biophys. Acta 1024, 352-366). Liposomal uptake by J774 mouse macrophage-like cells was time-dependent. Both the uptake and internalization were clearly reduced for PEG-liposomes compared to plain liposomes. Sterical stabilization reduced the general uptake of liposomes in vitro by more than 50% and the internalization by about 50-60%. PEG-liposomes additionally showed a delay in internalization into the macrophages during the first 6 h. Size of used liposomes had only a minor influence on liposomal uptake but highest concentration of lipid was found for large multilammelar vesicles (MLV). The fixed aqueous layer thickness (FALT) was determined by zeta potential measurements of plain and sterically stabilised HPC-liposomes (100 nm) in solutions of different ion concentrations. The calculation of the thickness was based on the linear correlation between ln zeta (zeta-potential) and kappa (Debye Hückel-Parameter). FALT was calculated and found to be for plain HPC-liposomes 0.83 +/- 0.17 nm and for PEG-HPC-liposomes 3.57 +/- 0.17 nm. Exchange of the HPC by an alkylphospholipid with different head group has no or only minor effect (PEG-OPP-liposomes 3.44 +/- 0.31 nm). Thus the reduced uptake of HPC-LUVET correlates with an increased thickness of the fixed aqueous layer around these liposomes and could support the hypothesis that the thickness is an important property responsible for preventing opsonization and resulting finally in a reduced macrophage uptake.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972708     DOI: 10.1016/s0005-2736(96)00167-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Preferential binding of polyethylene glycol-coated liposomes containing a novel cationic lipid, TRX-20, to human subendthelial cells via chondroitin sulfate.

Authors:  T Harigai; M Kondo; M Isozaki; H Kasukawa; H Hagiwara; H Uchiyama; J Kimura
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

2.  Activity of liposomal amphotericin B with prolonged circulation in blood versus those of AmBisome and fungizone against intracellular Candida albicans in murine peritoneal macrophages.

Authors:  E W van Etten; W van Vianen; J Hak; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

3.  Enhanced passive pulmonary targeting and retention of PEGylated rigid microparticles in rats.

Authors:  Hilliard L Kutscher; Piyun Chao; Manjeet Deshmukh; Sujata Sundara Rajan; Yashveer Singh; Peidi Hu; Laurie B Joseph; Stanley Stein; Debra L Laskin; Patrick J Sinko
Journal:  Int J Pharm       Date:  2010-09-29       Impact factor: 5.875

4.  PEGylation of a factor VIII-phosphatidylinositol complex: pharmacokinetics and immunogenicity in hemophilia A mice.

Authors:  Aaron Peng; Matthew P Kosloski; Genki Nakamura; Hong Ding; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2011-12-16       Impact factor: 4.009

5.  Liver Targeting of Daclatasvir via Tailoring Sterically Stabilized Bilosomes: Fabrication, Comparative In Vitro/In Vivo Appraisal and Biodistribution Studies.

Authors:  Mohamed El-Nabarawi; Mohamed Nafady; Shahira Elmenshawe; Marwa Elkarmalawy; Mahmoud Teaima
Journal:  Int J Nanomedicine       Date:  2021-09-17

6.  Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug.

Authors:  Olga B Garbuzenko; Maha Saad; Seema Betigeri; Min Zhang; Alexandre A Vetcher; Viatcheslav A Soldatenkov; David C Reimer; Vitaly P Pozharov; Tamara Minko
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

7.  A novel nanogel loaded with chitosan decorated bilosomes for transdermal delivery of terbutaline sulfate: artificial neural network optimization, in vitro characterization and in vivo evaluation.

Authors:  Shahira F El Menshawe; Heba M Aboud; Mohammed H Elkomy; Rasha M Kharshoum; Amany M Abdeltwab
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

8.  Use of Novasomes as a Vesicular Carrier for Improving the Topical Delivery of Terconazole: In Vitro Characterization, In Vivo Assessment and Exploratory Clinical Experimentation.

Authors:  Shaimaa Mosallam; Maha H Ragaie; Noha H Moftah; Ahmed Hassen Elshafeey; Aly Ahmed Abdelbary
Journal:  Int J Nanomedicine       Date:  2021-01-08

9.  Nanotransfersomes-loaded thermosensitive in situ gel as a rectal delivery system of tizanidine HCl: preparation, in vitro and in vivo performance.

Authors:  Fatma A Moawad; Adel A Ali; Heba F Salem
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

10.  Surface engineering of liposomes for stealth behavior.

Authors:  Okhil K Nag; Vibhudutta Awasthi
Journal:  Pharmaceutics       Date:  2013-10-25       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.